Financials

  • Market Capitalization 263.51 M
  • Employee 44
  • Founded 2015
  • CEO N/A
  • Website www.surrozen.com
  • Headquarter Delaware, United States
  • FIGI BBG00XY94S95
  • Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
-0.7
Relación precio/flujo de caja
0.05

Related tickers

#NombrePrecio24h %7d %1M %1A %CapitalizaciónÚltimos 7 días
3420
PYXS
Pyxis Oncology, Inc. - Common Stock
3.23 USD-2.71%+6.95%+9.49%+152.34%269.41 M USD
3428
SION
Sionna Therapeutics, Inc. - Common Stock
5.87 USD-3.14%+11.17%-86.87%-85.08%265.40 M USD
3433
WHWK
Whitehawk Therapeutics, Inc. - Common Stock
4.62 USD-5.13%-2.53%+25.54%+53.49%263.38 M USD
3435
MGNX
MacroGenics, Inc. - Common Stock
4.13 USD+1.23%+1.47%+10.13%+133.33%263.08 M USD

Noticias